Legis Daily

Lung Cancer Screening and Prevention Act of 2025

USA119th CongressHR-1406| House 
| Updated: 2/18/2025
Vern Buchanan

Vern Buchanan

Republican Representative

Florida

Cosponsors (8)
Darren Soto (Democratic)Darin LaHood (Republican)Paul Tonko (Democratic)H. Morgan Griffith (Republican)Timothy M. Kennedy (Democratic)Joe Neguse (Democratic)Robert P. Bresnahan (Republican)Debbie Wasserman Schultz (Democratic)

Ways and Means Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This legislative proposal aims to significantly broaden the scope of lung cancer screening services covered under the Medicare program by amending Section 1834(n) of the Social Security Act. It grants the Secretary of Health and Human Services new authority to authorize coverage for additional lung cancer screening tests. The core provision enables the Secretary to include tests that are cleared or approved by the Food and Drug Administration (FDA) as preventive services, beyond those currently covered. The Secretary will determine the appropriate individuals for these screenings, along with their frequency and payment limits, after consulting with relevant organizations. While utilizing the established national coverage determination process, the bill streamlines it by removing a specific determination requirement, allowing for more flexibility in adopting new screening technologies. This ensures that Medicare beneficiaries could have access to a wider range of advanced lung cancer detection methods. The amendments will take effect upon the bill's enactment, applying to preventive services covered under Medicare Part B.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 118-6693
Lung Cancer Screening and Prevention Act of 2023
Feb 18, 2025
Introduced in House
Feb 18, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • Bill from Previous Congress

    HR 118-6693
    Lung Cancer Screening and Prevention Act of 2023


  • February 18, 2025
    Introduced in House


  • February 18, 2025
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Health

CancerCardiovascular and respiratory healthHealth care coverage and accessHealth promotion and preventive careMedical tests and diagnostic methodsMedicare

Lung Cancer Screening and Prevention Act of 2025

USA119th CongressHR-1406| House 
| Updated: 2/18/2025
This legislative proposal aims to significantly broaden the scope of lung cancer screening services covered under the Medicare program by amending Section 1834(n) of the Social Security Act. It grants the Secretary of Health and Human Services new authority to authorize coverage for additional lung cancer screening tests. The core provision enables the Secretary to include tests that are cleared or approved by the Food and Drug Administration (FDA) as preventive services, beyond those currently covered. The Secretary will determine the appropriate individuals for these screenings, along with their frequency and payment limits, after consulting with relevant organizations. While utilizing the established national coverage determination process, the bill streamlines it by removing a specific determination requirement, allowing for more flexibility in adopting new screening technologies. This ensures that Medicare beneficiaries could have access to a wider range of advanced lung cancer detection methods. The amendments will take effect upon the bill's enactment, applying to preventive services covered under Medicare Part B.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 118-6693
Lung Cancer Screening and Prevention Act of 2023
Feb 18, 2025
Introduced in House
Feb 18, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • Bill from Previous Congress

    HR 118-6693
    Lung Cancer Screening and Prevention Act of 2023


  • February 18, 2025
    Introduced in House


  • February 18, 2025
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Vern Buchanan

Vern Buchanan

Republican Representative

Florida

Cosponsors (8)
Darren Soto (Democratic)Darin LaHood (Republican)Paul Tonko (Democratic)H. Morgan Griffith (Republican)Timothy M. Kennedy (Democratic)Joe Neguse (Democratic)Robert P. Bresnahan (Republican)Debbie Wasserman Schultz (Democratic)

Ways and Means Committee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
CancerCardiovascular and respiratory healthHealth care coverage and accessHealth promotion and preventive careMedical tests and diagnostic methodsMedicare